Harnessing multi-omics and AI for atherosclerotic cardiovascular disease management
Despite considerable life-saving progress, cardiovascular diseases (CVDs) remain the leading cause of death globally, claiming an estimated 17.9 …
Covers: HealthcareEnergy & EnvironmentChatbots & LLMsMarkets & InvestmentGovernance & Risk ManagementPrivacy & SurveillanceTransportation & MobilityEducationAI Safety & Existential RiskCybersecurity
Despite considerable life-saving progress, cardiovascular diseases (CVDs) remain the leading cause of death globally, claiming an estimated 17.9 …
Like any medical product,AI systems can poserisksto patients, sometimes in a novel way. ... There's ariskof AI magnifying bias already present in …
News-Medical.Net Our proposal uses a state-of-the-artartificial intelligencemodel thatrisk-profiles sleep apnea patients using data from routine sleep studies. Our …
The global prevalence of cardiovascular diseases (CVDs) is increasing rapidly, which has led to the development of several CVD prediction models. CVD …
News-Medical.Net Balancing benefits andrisks. WHO guidance advocates for a balanced approach to AI in healthcare, in which researchers maximize the benefits of AI for …
Artificial intelligence(AI) applications for treating hypertension (HTN) and its comorbidities …
News-Medical.net Researchers developed anAI-based model using facial, tongue, and retinal images to estimate biological age, offering a novel approach to predict …
News-Medical.net The lack of a personalizedriskmodel and accurate prediction system prevents physicians from recommending an extension of the screening interval …